NCT03922295

Brief Summary

Aim of this study is to compare results of double and single flap techniques for tympanoplasty in chronic suppurative otitis media patients. Inclusion criteria include total or subtotal tympanic membrane perforations with limited anterior remnant and should be dry for at least 3 months. Patients with persistent discharge, cholesteatoma, ossicular affection or those with recurrent perforations after previous myringoplasty were excluded. Also, patients with uncontrolled diabetes, chronic liver and kidney diseases and immuno-compromised patients are not included in this study. Patients are divided into two groups, endoscopic double flap group and endoscopic single flap group. Healing and hearing outcomes were evaluated 3 months postoperative. Also, post-operative pain scores and complications were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 19, 2019

Completed
Last Updated

September 10, 2019

Status Verified

September 1, 2019

Enrollment Period

1.5 years

First QC Date

April 16, 2019

Last Update Submit

September 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Healing or graft take rate

    closure of tympanic membrane perforation

    3 months after surgery

Study Arms (2)

endoscopic double flap group

ACTIVE COMPARATOR
Procedure: Endoscopic tympanoplasty

endoscopic single flap group

ACTIVE COMPARATOR
Procedure: Endoscopic tympanoplasty

Interventions

In the double flap group, graft is placed via elevation of both posterior and anterior flaps. In the single flap group, graft is placed via elevation of posterior flap only

endoscopic double flap groupendoscopic single flap group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with chronic suppurative otitis media with total or subtotal tympanic membrane perforation with limited anterior remnant.
  • dry perforation for at least 3 months.

You may not qualify if:

  • Recurrent perforation after previous myringoplasty.
  • Ossicular disruption or fixation.
  • immune-compromised patients including uncontrolled diabetics, chronic liver and kidney diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ORL-HNS department,Mansoura University Hospital, Faculty of Medicine, Mansoura University

Al Mansurah, ElDakahlia, 35516, Egypt

Location

Related Publications (1)

  • El-Kholy NA, Salem MA, Rakha AM. Endoscopic single versus double flap tympanoplasty: a randomized clinical trial. Eur Arch Otorhinolaryngol. 2021 May;278(5):1395-1401. doi: 10.1007/s00405-020-06212-3. Epub 2020 Jul 20.

MeSH Terms

Conditions

Tympanic Membrane Perforation

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesWounds and Injuries

Study Officials

  • Noha A Elkholy

    ORL-HNS department, Faculty of Medicine, Mansoura University

    PRINCIPAL INVESTIGATOR
  • Mohammed A Salem

    ORL-HNS department, Faculty of Medicine, Mansoura University

    STUDY DIRECTOR
  • Abdelwahab M Rakha

    ORL-HNS department, Faculty of Medicine, Mansoura University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ORL-HNS Resident

Study Record Dates

First Submitted

April 16, 2019

First Posted

April 19, 2019

Study Start

August 24, 2017

Primary Completion

February 20, 2019

Study Completion

February 20, 2019

Last Updated

September 10, 2019

Record last verified: 2019-09

Locations